Company Performance Metrics
- Bugra Cakmak: Co-Founder & CTO
Bash Biotech specializes in developing innovative treatment strategies for neurological and kidney diseases by leveraging the power of artificial intelligence and systems biology. With a focus on biotechnology research, the company is engaged in the discovery and development of therapeutic solutions aimed at improving patient outcomes. Bash
Biotech's research portfolio includes projects targeting chronic kidney disease, kidney cancer, and Alzheimer's disease. The company employs a team of experts dedicated to advancing the field of biotechnology and making significant contributions to medical science.